Business
Invitation to FluoGuide A/S (Nasdaq:FLUO) Webcast on 28 August 2025
KØBENHAVN, DK / ACCESS Newswire / August 22, 2025 / FluoGuide A/S (STO:FLUO) - FluoGuide A/S will publish its Interim Report Q2 2025 on Thursday 28 August 2025. The following event will take place later that day: A live webcast for shareholders, analysts, ...
About this update from Fluoguide A/s
[{"type":"text","content":"KØBENHAVN, DK / ACCESS Newswire / August 22, 2025 / FluoGuide A/S (STO:FLUO) - FluoGuide A/S will publish its Interim Report Q2 2025 on Thursday 28 August 2025.","length":160,"tagName":"p"},{"type":"text","content":"The following event will take place later that day:","length":51,"tagName":"p"},{"type":"text","content":"A live webcast for shareholders, analysts, investors and representatives of the media:","length":86,"tagName":"p"},{"type":"text","content":"Topic: FluoGuide Operational and Financial Results for Q2 2025Date: Thursday 28 August 2025Time: 14.00 CET","length":108,"tagName":"p"},{"type":"text","content":"The webcast is hosted by analyst Christian Binder, Redeye. FluoGuide is represented by CEO Morten Albrechtsen and CFO Ole Larsen.","length":129,"tagName":"p"},{"type":"text","content":"Please login to the webcast via the following link: https://www.redeye.se/events/1124137/live-q-fluoguide","length":105,"tagName":"p"},{"type":"text","content":"Questions can be sent in advance by email to Christian Binder ( [email protected] ) or can be raised at the question session during the webcast.","length":153,"tagName":"p"},{"type":"text","content":"A recorded version of the presentation will be available on the website after the webcast has concluded.","length":104,"tagName":"p"},{"type":"text","content":"For further information, please contact:Morten Albrechtsen, CEOFluoGuide A/SPhone: +45 24 25 62 66E-mail: [email protected]","length":126,"tagName":"p"},{"type":"text","content":"Follow FluoGuide on linkedInFollow FluoGuide on LinkedIn: https://www.linkedin.com/company/fluoguide/","length":102,"tagName":"p"},{"type":"text","content":"Sign up to receive FluoGuide newsSign up to receive FluoGuide news: https://fluoguide.com/investor/email-alerts/","length":113,"tagName":"p"},{"type":"text","content":"About FluoGuideFluoGuide's primary focus is to maximize surgical outcomes in oncology. FluoGuide's lead product, FG001, is designed to improve surgical precision by illuminating cancer cells intraoperatively. The improved precision enabled by FluoGuide's products has a dual benefit - it reduces both the frequency of local recurrence post-surgery and lessens surgical sequelae. Ultimately, this improved precision enhances the likelihood of achieving a complete cure and helping to lower healthcare costs. FluoGuid...